Dr Reddys Laboratories (RDY) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $135.8 million.
- Dr Reddys Laboratories' Income towards Parent Company fell 1884.12% to $135.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $319.9 million, marking a year-over-year decrease of 3260.2%. This contributed to the annual value of $663.0 million for FY2025, which is 143.73% down from last year.
- Dr Reddys Laboratories' Income towards Parent Company amounted to $135.8 million in Q4 2025, which was down 1884.12% from $184.1 million recorded in Q1 2025.
- In the past 5 years, Dr Reddys Laboratories' Income towards Parent Company registered a high of $184.1 million during Q1 2025, and its lowest value of $152.0 during Q3 2022.
- Its 5-year average for Income towards Parent Company is $130.1 million, with a median of $149.9 million in 2024.
- In the last 5 years, Dr Reddys Laboratories' Income towards Parent Company crashed by 9999.98% in 2022 and then skyrocketed by 11778634501.85% in 2023.
- Over the past 5 years, Dr Reddys Laboratories' Income towards Parent Company (Quarter) stood at $11.0 million in 2021, then soared by 962.09% to $116.8 million in 2022, then soared by 41.75% to $165.6 million in 2023, then increased by 1.08% to $167.4 million in 2024, then fell by 18.84% to $135.8 million in 2025.
- Its last three reported values are $135.8 million in Q4 2025, $184.1 million for Q1 2025, and $167.4 million during Q4 2024.